Eye Scan Drug Testing Database | eyegage

The Genesis of EyeGage and its Innovative Approach

LaVonda Brown’s initial exploration of eye-tracking technology occurred during her studies at Georgia Tech. This early interest, stemming from the wealth of information obtainable through analyzing the “windows to the soul,” ultimately led to the creation of EyeGage. The company is currently participating as one of twenty competitors in this year’s Disrupt Startup Battlefield.

Introducing the First Product: A Sobriety Assessment App

EyeGage’s debut in the TechCrunch competition coincides with the launch of its inaugural product. This application is designed to assist users in determining their fitness to drive. Should the app detect impairment, a clear “Do Not Drive” warning is displayed, accompanied by convenient links to summon either Uber or Lyft. The application is available at no cost and serves a dual function.

A Barter System for Data Acquisition

Beyond its consumer-facing utility, the app functions as a voluntary opt-in for EyeGage’s expanding database of ocular data. “Users can download the application, submit images and videos of their eyes, and receive a recommendation regarding ride-sharing services – essentially, whether or not they should drive – based on the analysis of their eyes,” Brown clarifies. “This service is free; we consider it a barter subscription. Users provide us with ocular data, and in return, they gain access to technology that supports responsible decision-making.”

Building a Comprehensive Ocular Dataset

Currently, the app represents the most visible aspect of EyeGage’s operations. Like much of the company’s work, its primary goal is to enhance its collection of ocular data. The company is initiating research into the effects of alcohol on various ocular characteristics, conducting studies with participants in a government-approved testing environment.

Participants who provide informed consent will consume alcoholic beverages while the company records images and videos of their eyes, alongside corresponding blood samples.

Expanding Research to Include Marijuana and Other Substances

Following alcohol, marijuana is the next substance targeted for study, given its increasing legal acceptance in numerous states. Acquiring data on other drugs, such as opioids, amphetamines, and benzodiazepines, will present greater challenges. However, hospitals and clinics dispensing legally prescribed versions of these substances could potentially serve as valuable data sources, contingent upon obtaining appropriate consent.

Targeting High-Risk Environments

Brown also identifies workplace safety as a logical area for expansion. She notes, “We’re focusing on high-risk workplaces like construction, manufacturing, and transportation, where rates of drug and alcohol use are notably elevated.” Law enforcement agencies are also being considered, although establishing such partnerships involves navigating various obstacles.

Potential Beyond Substance Detection

The company’s dataset holds potential applications extending beyond the immediate detection of substances within the body.

The Broad Applications of Eye Behavior Monitoring

“Analyzing eye movements has applications across numerous fields,” Brown emphasizes. “Furthermore, the eyes can be used for individual identification. They can aid in the diagnosis of conditions like illnesses, concussions, or diabetes, and find utility in diverse market segments. The eyes provide significant insights into bodily functions. They can even indicate caffeine intake based on their reaction to light – a rapid response suggests a stimulant, while a slower response indicates a depressant.”

Funding and Investment

To date, EyeGage has secured $142,455 in funding. This includes $42,455 in pre-seed capital from friends and family, as well as a recent $100,000 award from the Google Black Founders Fund.